The werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication

Anima Sharma, Soumya Awasthi, Carolyn K. Harrod, Elizabeth F. Matlock, Saiqa Khan, Louisa Xu, Stephanie Chan, Helen Yang, Charu K. Thammavaram, Randall A. Rasor, Dennis K. Burns, Daniel J. Skiest, Carine Van Lint, Anne Marie Girard, Monnie McGee, Raymond J. Monnat, Robert Harrod

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The Werner syndrome helicase (WRN) participates in DNA replication, double strand break repair, telomere maintenance, and p53 activation. Mutations of wrn cause Werner syndrome (WS), an autosomal recessive premature aging disorder associated with cancer predisposition, atherosclerosis, and other aging related symptoms. Here, we report that WRN is a novel cofactor for HIV-1 replication. Immortalized human WRN-/- WS fibroblasts, lacking a functional wrn gene, are impaired for basal and Tat-activated HIV-1 transcription. Overexpression of wild-type WRN transactivates the HIV-1 long terminal repeat (LTR) in the absence of Tat, and WRN cooperates with Tat to promote high-level LTR transactivation. Ectopic WRN induces HIV-1 p24Gag production and retroviral replication in HIV-1-infected H9HIV-1IIIB lymphocytes. A dominant-negative helicase-minus mutant, WRNK577M, inhibits LTR transactivation and HIV-1 replication. Inhibition of endogenous WRN, through co-expression of WRNK577M, diminishes recruitment of p300/CREB-binding protein-associated factor (PCAF) and positive transcription elongation factor b (P-TEFb) to Tat/transactivation response-RNA complexes, and immortalized WRN-/- WS fibroblasts exhibit comparable defects in recruitment of PCAF and P-TEFb to the HIV-1 LTR. Our results demonstrate that WRN is a novel cellular cofactor for HIV-1 replication and suggest that the WRN helicase participates in the recruitment of PCAF/P-TEFb-containing transcription complexes. WRN may be a plausible target for antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)12048-12057
Number of pages10
JournalJournal of Biological Chemistry
Volume282
Issue number16
DOIs
StatePublished - Apr 20 2007

Fingerprint

HIV Long Terminal Repeat
Terminal Repeat Sequences
Transcription
Transcriptional Activation
HIV-1
Peptide Elongation Factors
Werner Syndrome
Fibroblasts
Aging of materials
Transcription Factors
Lymphocytes
Premature Aging
Repair
Genes
Chemical activation
Werner Syndrome Helicase
RNA
Telomere
DNA Replication
Defects

ASJC Scopus subject areas

  • Biochemistry

Cite this

The werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication. / Sharma, Anima; Awasthi, Soumya; Harrod, Carolyn K.; Matlock, Elizabeth F.; Khan, Saiqa; Xu, Louisa; Chan, Stephanie; Yang, Helen; Thammavaram, Charu K.; Rasor, Randall A.; Burns, Dennis K.; Skiest, Daniel J.; Van Lint, Carine; Girard, Anne Marie; McGee, Monnie; Monnat, Raymond J.; Harrod, Robert.

In: Journal of Biological Chemistry, Vol. 282, No. 16, 20.04.2007, p. 12048-12057.

Research output: Contribution to journalArticle

Sharma, A, Awasthi, S, Harrod, CK, Matlock, EF, Khan, S, Xu, L, Chan, S, Yang, H, Thammavaram, CK, Rasor, RA, Burns, DK, Skiest, DJ, Van Lint, C, Girard, AM, McGee, M, Monnat, RJ & Harrod, R 2007, 'The werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication', Journal of Biological Chemistry, vol. 282, no. 16, pp. 12048-12057. https://doi.org/10.1074/jbc.M608104200
Sharma, Anima ; Awasthi, Soumya ; Harrod, Carolyn K. ; Matlock, Elizabeth F. ; Khan, Saiqa ; Xu, Louisa ; Chan, Stephanie ; Yang, Helen ; Thammavaram, Charu K. ; Rasor, Randall A. ; Burns, Dennis K. ; Skiest, Daniel J. ; Van Lint, Carine ; Girard, Anne Marie ; McGee, Monnie ; Monnat, Raymond J. ; Harrod, Robert. / The werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 16. pp. 12048-12057.
@article{549f8a0e665a4f6196a2017d5e456634,
title = "The werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication",
abstract = "The Werner syndrome helicase (WRN) participates in DNA replication, double strand break repair, telomere maintenance, and p53 activation. Mutations of wrn cause Werner syndrome (WS), an autosomal recessive premature aging disorder associated with cancer predisposition, atherosclerosis, and other aging related symptoms. Here, we report that WRN is a novel cofactor for HIV-1 replication. Immortalized human WRN-/- WS fibroblasts, lacking a functional wrn gene, are impaired for basal and Tat-activated HIV-1 transcription. Overexpression of wild-type WRN transactivates the HIV-1 long terminal repeat (LTR) in the absence of Tat, and WRN cooperates with Tat to promote high-level LTR transactivation. Ectopic WRN induces HIV-1 p24Gag production and retroviral replication in HIV-1-infected H9HIV-1IIIB lymphocytes. A dominant-negative helicase-minus mutant, WRNK577M, inhibits LTR transactivation and HIV-1 replication. Inhibition of endogenous WRN, through co-expression of WRNK577M, diminishes recruitment of p300/CREB-binding protein-associated factor (PCAF) and positive transcription elongation factor b (P-TEFb) to Tat/transactivation response-RNA complexes, and immortalized WRN-/- WS fibroblasts exhibit comparable defects in recruitment of PCAF and P-TEFb to the HIV-1 LTR. Our results demonstrate that WRN is a novel cellular cofactor for HIV-1 replication and suggest that the WRN helicase participates in the recruitment of PCAF/P-TEFb-containing transcription complexes. WRN may be a plausible target for antiretroviral therapy.",
author = "Anima Sharma and Soumya Awasthi and Harrod, {Carolyn K.} and Matlock, {Elizabeth F.} and Saiqa Khan and Louisa Xu and Stephanie Chan and Helen Yang and Thammavaram, {Charu K.} and Rasor, {Randall A.} and Burns, {Dennis K.} and Skiest, {Daniel J.} and {Van Lint}, Carine and Girard, {Anne Marie} and Monnie McGee and Monnat, {Raymond J.} and Robert Harrod",
year = "2007",
month = "4",
day = "20",
doi = "10.1074/jbc.M608104200",
language = "English (US)",
volume = "282",
pages = "12048--12057",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "16",

}

TY - JOUR

T1 - The werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication

AU - Sharma, Anima

AU - Awasthi, Soumya

AU - Harrod, Carolyn K.

AU - Matlock, Elizabeth F.

AU - Khan, Saiqa

AU - Xu, Louisa

AU - Chan, Stephanie

AU - Yang, Helen

AU - Thammavaram, Charu K.

AU - Rasor, Randall A.

AU - Burns, Dennis K.

AU - Skiest, Daniel J.

AU - Van Lint, Carine

AU - Girard, Anne Marie

AU - McGee, Monnie

AU - Monnat, Raymond J.

AU - Harrod, Robert

PY - 2007/4/20

Y1 - 2007/4/20

N2 - The Werner syndrome helicase (WRN) participates in DNA replication, double strand break repair, telomere maintenance, and p53 activation. Mutations of wrn cause Werner syndrome (WS), an autosomal recessive premature aging disorder associated with cancer predisposition, atherosclerosis, and other aging related symptoms. Here, we report that WRN is a novel cofactor for HIV-1 replication. Immortalized human WRN-/- WS fibroblasts, lacking a functional wrn gene, are impaired for basal and Tat-activated HIV-1 transcription. Overexpression of wild-type WRN transactivates the HIV-1 long terminal repeat (LTR) in the absence of Tat, and WRN cooperates with Tat to promote high-level LTR transactivation. Ectopic WRN induces HIV-1 p24Gag production and retroviral replication in HIV-1-infected H9HIV-1IIIB lymphocytes. A dominant-negative helicase-minus mutant, WRNK577M, inhibits LTR transactivation and HIV-1 replication. Inhibition of endogenous WRN, through co-expression of WRNK577M, diminishes recruitment of p300/CREB-binding protein-associated factor (PCAF) and positive transcription elongation factor b (P-TEFb) to Tat/transactivation response-RNA complexes, and immortalized WRN-/- WS fibroblasts exhibit comparable defects in recruitment of PCAF and P-TEFb to the HIV-1 LTR. Our results demonstrate that WRN is a novel cellular cofactor for HIV-1 replication and suggest that the WRN helicase participates in the recruitment of PCAF/P-TEFb-containing transcription complexes. WRN may be a plausible target for antiretroviral therapy.

AB - The Werner syndrome helicase (WRN) participates in DNA replication, double strand break repair, telomere maintenance, and p53 activation. Mutations of wrn cause Werner syndrome (WS), an autosomal recessive premature aging disorder associated with cancer predisposition, atherosclerosis, and other aging related symptoms. Here, we report that WRN is a novel cofactor for HIV-1 replication. Immortalized human WRN-/- WS fibroblasts, lacking a functional wrn gene, are impaired for basal and Tat-activated HIV-1 transcription. Overexpression of wild-type WRN transactivates the HIV-1 long terminal repeat (LTR) in the absence of Tat, and WRN cooperates with Tat to promote high-level LTR transactivation. Ectopic WRN induces HIV-1 p24Gag production and retroviral replication in HIV-1-infected H9HIV-1IIIB lymphocytes. A dominant-negative helicase-minus mutant, WRNK577M, inhibits LTR transactivation and HIV-1 replication. Inhibition of endogenous WRN, through co-expression of WRNK577M, diminishes recruitment of p300/CREB-binding protein-associated factor (PCAF) and positive transcription elongation factor b (P-TEFb) to Tat/transactivation response-RNA complexes, and immortalized WRN-/- WS fibroblasts exhibit comparable defects in recruitment of PCAF and P-TEFb to the HIV-1 LTR. Our results demonstrate that WRN is a novel cellular cofactor for HIV-1 replication and suggest that the WRN helicase participates in the recruitment of PCAF/P-TEFb-containing transcription complexes. WRN may be a plausible target for antiretroviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=34249717335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249717335&partnerID=8YFLogxK

U2 - 10.1074/jbc.M608104200

DO - 10.1074/jbc.M608104200

M3 - Article

VL - 282

SP - 12048

EP - 12057

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 16

ER -